Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review.
Jenny LeeYasaman ValiJerome BoursierRene SpijkerQuentin Mark AnsteePatrick M BossuytMohammad H ZafarmandPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
FIB-4, NFS, and APRI have demonstrated ability to risk stratify patients for liver-related morbidity and mortality, with comparable performance to a liver biopsy, although more head-to-head studies are needed to validate this. More refined models to prognosticate NAFLD-events may further enhance performance and clinical utility of non-invasive markers.